TipRanks on MSN

Inovio 13.16M share Spot Secondary priced at $1.90

Pharmaceuticals announced the pricing of an underwritten public offering of 13,158,000 shares of its common stock at a public ...
The Pharma Letter

Inovio plans public offering to fund DNA medicine development

US biotech Inovio (Nasdaq: INO) said it plans to offer and sell shares of its common stock in an underwritten public offering ...

INOVIO stock falls after pricing $25 million public offering at discount

Investing.com -- INOVIO Pharmaceuticals Inc. (NASDAQ:INO) shares fell 10% after the biotechnology company announced the pricing of an underwritten public offering at $1.90 per share, representing a ...
The Malaysian Reserve

INOVIO Reports Third Quarter 2025 Financial Results and Recent Business Highlights

Completed rolling Biologics License Application (BLA) submission seeking accelerated approval for lead candidate INO-3107; requested priority review ...
InvestorsHub on MSN

INOVIO Shares Drop 10% After Discounted $25 Million Public Offering

INOVIO Pharmaceuticals Inc. (NASDAQ:INO) shares fell 10% in early trading after the biotech company announced the pricing of ...

Inovio Shares Sink After Pricing $25M Public Offering

Ahead of the opening bell, the drugmaker said it plans to sell about 13.2 million shares of common stock at $1.90 apiece. Inovio will also grant underwriters a 30-day option to purchase up to nearly 2 ...